Antigen-presenting cells in nasal allergy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 11, 1999, Pages 1130-1141

  Fokkens, W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC RHINITIS; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CORTICOSTEROID THERAPY; DENDRITIC CELL; HUMAN; LANGERHANS CELL; NOSE ALLERGY; NOSE MUCOSA; PRIORITY JOURNAL; REVIEW; SECONDARY IMMUNE RESPONSE; SENSITIZATION;

ADRENAL CORTEX HORMONES; ALLERGENS; ANIMALS; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; HUMANS; LANGERHANS CELLS; MACROPHAGES; MONOCYTES; NASAL MUCOSA; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 0032701442     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00104.x     Document Type: Review

References (158)

1. 1. Mygind N, Dahl R, Pedersen S, Thestrup-Pedersen K. Essential allergy. Oxford: Blackwell Science, 1996.
2. 2. Warner JA, Jones AC, Miles EA, Colwell BM, Warner JO. Prenatal origins of asthma and allergy. Ciba Found Symp 1997;206:220-228.
3. 3. Wahn U, Bergmann R, Kulig M, Forster J, Bauer CP. The natural course of sensitisation and atopic disease in infancy and childhood. Pediatr Allergy Immunol 1997;8 Suppl 10:16-20.
4. 4. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392(6673):245-252.
5. 5. Austyn JM,.Dendritic cells. Curr Opin Hematol 1998;5:1-15.
6. 6. Reyes VE, Ye G, Ogra PL, Garofalo R. Antigen presentation of mucosal pathogens: the players and the rules. Int Arch Allergy Immunol 1997;112:103-114.
7. 7. Pieters J. MHC class II compartments: specialized organelles of the endocytic pathway in antigen presenting cells. Biol Chem 1997;378:751-758.
8. 8. Jensen PE. Antigen unfolding and disulfide reduction in antigen presenting cells. Semin Immunol 1995;7:347-353.
9. 9. Schneider SC, Sercarz EE. Antigen processing differences among APC. Hum Immunol 1997;54:148-158.
10. 10. Inaba K, Metlay JP, Crowley MT, Witmer-Pack M, Steinman RM. Dendritic cells as antigen presenting cells in vivo. Int Rev Immunol 1990;6:197-206.
11. 11. Somasse T, Flamand V, De Becker G, et al. Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J Exp Med 1992;175:15-21.
12. 12. Mellman I, Turley SJ, Steinman RM. Antigen processing for amateurs and professionals. Trends Cell Biol 1998;8:231-237.
13. 13. Wagner CR, Vetto RM, Burger DR. Subcultured human endothelial cells can function independently as fully competent antigen-presenting cells. Hum Immunol 1985;13:33-47.
14. 14. Geppert TD, Lipsky PE. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. J Immunol 1985;135:3750-3762.
15. 15. Bal V, McIndoe A, Denton G, et al. Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol 1990;20:1893-1897.
16. 16. Kalb TH, Chuang MT, Marom Z, Mayer L. Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. Am J Respir Cell Mol Biol 1991;4:320-329.
17. 17. Mircheff AK, Gierow JP, Lee LM, Lambert RW, Akashi RH, Hofman FM. Class II antigen expression by lacrimal epithelial cells. An updated working hypothesis for antigen presentation by epithelial cells. Invest Ophthalmol Vis Sci 1991;32:2302-2310.
18. 18. Pawankar R, Ra C. IgE-Fc epsilonRI-mast cell axis in the allergic cycle. Clin Exp Allergy 1998;28 Suppl 3:6-14.
19. 19. Toru H, Pawankar R, Ra C, Yata J, Nakahata T. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells. J Allergy Clin Immunol 1998;102:491-502.
20. 20. Polosa R, Crimi N. Exposing the mast cell: its novel integrated role in allergy. Ann Ital Med Int 1998;13:78-80.
21. 21. Weller PF, Rand TH, Barrett T, Elovic A, Wong DT, Finberg RW. Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol 1993;150:2554-2562.
22. 22. Smith WB, Guida L, Sun Q, et al. Neutrophils activated by granulocyte-macrophage colony-stimulating factor express receptors for interleukin-3 which mediate class II expression. Blood 1995;86:3938-3944.
23. 23. Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA. Dendritic cells are required for the development of chronic cosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 1998;160:4090-4097.
24. 24. Caux C, Massacrier C, Dezutter-Dambuyant C, et al. Human dendritic Langerhans cells generated in vitro from CD34+ progenitors can prime naive CD4+ T cells and process soluble antigen. J Immunol 1995;155:5427-5435.
25. 25. Bruijnzeel-Koomen CA, Mudde GC, Bruijnzeel PL. The presence of IgE molecules on epidermal Langerhans cells in atopic dermatitis and their significance for its pathogenesis. Allerg Immunol (Paris) 1989;21:219-223.
26. 26. Fokkens WJ, Broekhuis-Fluitsma DM, Rijntjes E, Vroom TM, Hoefsmit ECM. Langerhans cells in nasal mucosa of patients with grass-pollen allergy. Immunobiology 1991;182:135-142.
27. 27. Soler P, Moreau A, Basset F, Hance AJ. Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendritic cells/Langerhans cells. Am Rev Respir Dis 1989;139:1112-1117.
28. 28. Moller GM, Overbeek SE, van Helden-Meeuwsen CG, et al. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy 1996;26:517-514.
29. 29. Barrett AW, Cruchley AT, Williams DM. Oral mucosal Langerhans' cells. Crit Rev Oral Biol Med 1996;7:36-58.
30. 30. van Wilsem EJ, van Hoogstraten IM, Breve J, Scheper RJ, Kraal G. Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immunology 1994;83:128-132.
31. 31. Pavli P, Hume DA, Van De Pol E, Doe WF. Dendritic cells, the major antigen-presenting cells of the human colonic lamina propria. Immunology 1993;78:132-141.
32. 32. Fokkens WJ, Bruijnzeel-Koomen CAFM, Vroom TM, et al. The Langerhans cell: an underestimated cell in atopic disease. Clin Exp Allergy 1990;20:627-638.
33. 33. Balfour BM, Drexhage HA, Kamperdijk EW, Hoefsmit EC. Antigen-presenting cells, including Langerhans cells, veiled cells and interdigitating cells. Ciba Found Symp 1981;84:281-301.
34. 34. Fokkens WJ, Vinke JG, De Jong SS, Bogaert DP, Kleinjan A, Eichhorn E. Differences in cellular infiltrates in the adenoid of allergic children compared with age-and gender-matched controls. Clin Exp Allergy 1998;28:187-195.
35. 35. Havenith CE, van Miert PP, Breedijk AJ, Beelen RH, Hoefsmit EC. Migration of dendritic cells into the draining lymph nodes of the lung after intratracheal instillation. Am J Respir Cell Mol Biol 1993;9:484-488.
36. 36. Sminia T, Wilders MM, Janse EM, Hoefsmit EC. Characterization of nonlymphoid cells in Peyer's patches of the rat. Immunobiology 1983;164:136-143.
37. 37. Drexhage HA, Mullink H, de Groot J, Clarke J, Balfour BM. A study of cells present in peripheral lymph of pigs with special reference to a type of cell resembling the Langerhans cell. Cell Tissue Res 1979;202:407-430.
38. 38. Inaba K, Witmer-Pack M, Inaba M, et al., The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994;180:1849-1860.
39. 39. Caux C, Vanbervliet B, Massacrier C, et al. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med 1994;180:1841-1847.
40. 40. Ohshima Y, Yang LP, Uchiyama T, et al. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood 1998;92:3338-3345.
41. 41. van Kooten C, Banchereau J. Functional role of CD40 and its ligand. Int Arch Allergy Immunol 1997;113:393-399.
42. 42. McWilliam AS, Napoli S, Marsh AM, et al. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J Exp Med 1996;184:2429-2432.
43. 43. Schuler G, Thurner B, Romani N. Dendritic cells: from ignored cells to major players in T-cell-mediated immunity. Int Arch Allergy Immunol 1997;112:317-322.
44. 44. Shortman K, Caux C. Dendritic cell development: multiple pathways to nature's adjuvants. Stem Cells 1997,15:409-419.
45. 45. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products [see comments]. J Exp Med 1995;182:389-400.
46. 46. Herbst B, Kohler G, Mackensen A, et al. In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the Birbeck granule and MHC-positive Langerhans cell and the interdigitating dendritic cell type. Blood 1996;88:2541-2548.
47. 47. Mackensen A, Herbst B, Kohler G, et al. Delineation of the dendritic cell lineage by generating large numbers of Birbeck granule-positive Langerhans cells from human peripheral blood progenitor cells in vitro. Blood 1995;86:2699-2707.
48. 48. Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999;223:77-92.
49. 49. Poulter LW. Antigen presenting cells in situ: their identification and involvement in immunopathology. Clin Exp Immunol 1983;53:513-520.
50. 50. Godthelp T, Fokkens WJ, Kleinjan A, et al. Antigen presenting cells in the nasal mucosa of patients with allergic rhinitis during allergen provocation. Clin Exp Allergy 1996;26:677-688.
51. 51. Fokkens WJ, Vroom TM, Rijntjes E, Mulder PGH. CD1a(T6), HLA-DR-expressing cells, presumably Langerhans cells, in nasal mucosa. Allergy 1989;44:167-172.
52. 52. Silberberg-Sinakin I, Thorbecke GJ, Baer RL, Rosenthal SA, Berezowsky V. Antigen-bearing Langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol 1976;25:137-151.
53. 53. Hoefsmit EC, Balfour BM, Kamperdijk EW, Cvetanov J. Cells containing Birbeck granules in the lymph and the lymph node. Adv Exp Med Biol 1979;114:389-394.
54. 54. Hoefsmit EC. Macrophages, Langerhans cells, interdigitating and dendritic accessory cells: a summary. Adv Exp Med Biol 1982;149:463-468.
55. 55. Romani N, Schuler G. Structural and functional relationships between epidermal Langerhans cells and dendritic cells. Res Immunol 1989;140:895-898.
56. 56. Romani N, Lenz A, Glassel H, et al. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol 1989;93:600-609.
57. 57. Hanau D, Fabre M, Schmitt DA, et al. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens). Proc Natl Acad Sci U S A 1987;84:2901-2905.
58. 58. Murphy GF, Bhan AK, Harrist TJ, Mihm MC Jr. In situ identification of T6-positive cells in normal human dermis by immunoelectron microscopy. Br J Dermatol 1983;108:423-431.
59. 59. Hanau D, Fabre M, Schmitt DA, et al. Human epidermal Langerhans cells internalize by receptor-mediated endocytosis T6 (CD1 "NA1/34") surface antigen. Birbeck granules are involved in the intracellular traffic of the T6 antigen. J Invest Dermatol 1987;89:172-177.
60. 60. Jackman RM, Moody DR, Porcelli SA. Mechanisms of lipid antigen presentation by CD1. Crit Rev Immunol 1999;19:49-63.
61. 61. Braud VM, Allan DS, McMichael AJ. Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr Opin Immunol 1999;11:100-108.
62. 62. Sugita M, Moody DB, Jackman RM, et al. CD1 - a new paradigm for antigen presentation and T cell activation. Clin Immunol Immunopathol 1998;87:8-14.
63. 63. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-296.
64. 64. Romani N, Schuler G. The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system. Springer Semin Immunopathol 1992;13:265-279.
65. 65. Cumberbatch M, Gould SJ, Peters SW, Kimber I, MHC class II expression by Langerhans' cells and lymph node dendritic cells: possible evidence for maturation of Langerhans' cells following contact sensitization. Immunology 1991;74:414-419.
66. 66. Teunissen MB. Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells. Histochem J 1992;24:697-716.
67. 67. de la Salle H, Haegel-Kronenberger H, Bausinger H, et al. Functions of Fc receptors on human dendritic Langerhans cells. Int Rev Immunol 1997;16:187-203.
68. 68. Heufler C, Koch F, Schuler G. Granulocyte/ macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 1988;167:700-705.
69. 69. Smith CH, Allen MH, Groves RW, Barker JN. Effect of granulocyte macrophage-colony stimulating factor on Langerhans cells in normal and healthy atopic subjects. Br J Dermatol 1998;139:239-246.
70. 70. Stampfli MR, Wiley RE, Neigh GS, et al. GM-CSF transgene expression in the airway allows acrosolized ovalbumin to induce allergic sensitization in mice. J Clin Invest 1998;102:1704-1714.
71. 71. Lanzavecchia A. Mechanisms of antigen uptake for presentation. Curr Opin Immunol 1996;8:348-354.
72. 72. Lambrecht BN, Pauwels RA, Bullock GR. The dendritic cell: its potent role in the respiratory immune response. Cell Biol Int 1996;20:111-120.
73. 73. Montaner LJ, da Silva RP, Sun J, et al. Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-gamma or IL-10. J Immunol 1999;162:4606-4613.
74. 74. Mudde GC, Hansel TT, von Reijsen FC, Osterhoff BF, Bruijnzeel-Koomen CA. IgE: an immunoglobulin specialized in antigen capture? (see comments). Immunol Today 1990;11:440-443.
75. 75. Mudde GC, Bheekha R, Bruijnzeel-Koomen CA. IgE-mediated antigen presentation. Allergy 1995;50:193-199.
76. 76. Mudde GC, Reischul IG, Corvaia N, Hren A, Poellabauer EM. Antigen presentation in allergic sensitization. Immunol Cell Biol 1996;74:167-173.
77. 77. Stingl G, Maurer D. IgE-mediated allergen presentation via Fc epsilon RI on antigen-presenting cells. Int Arch Allergy Immunol 1997;113:24-29.
78. 78. Persson CG, Erjefält JS, Greiff L, et al. Contribution of plasma-derived molecules to mucosal immune defence, disease and repair in the airways. Scand J Immunol 1998;47:302-313.
79. 79. Poliquin JF, Crepeau J. Immune defence mechanisms of the nasal mucosa. J Otolaryngol 1985;14:80-84.
80. 80. Brandtzaeg P, Jahnsen FL, Farstad IN. Immune functions and immunopathology of the mucosa of the upper respiratory pathways. Acta Otolaryngol (Stockh) 1996;116:149-159.
81. 81. McMenamin C, Schon-Hegrad M, Oliver J, Girn B, Holt PG. Regulation of IgE responses to inhaled antigens: cellular mechanisms underlying allergic sensitization versus tolerance induction. Int Arch Allergy Appl Immunol 1991;94:78-82.
82. 82. McMenamin C, Pimm C, McKersey M, Holt PG. Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells. Science 1994;265(5180):1869-1871.
83. 83. Holt PG. Immune tolerance and protection against allergic sensitization. Allergy 1995;50 Suppl 25:34-36.
84. 84. Bellanti JA. Cytokines and allergic diseases: clinical aspects. Allergy Asthma Proc 1998;19:337-341.
85. 85. Kay AB. T cells as orchestrators of the asthmatic response. Ciba Found Symp 1997;206:56-67;67-70;106-110.
86. 86. Holt PG, Macaubas C, Cooper D, Nelson DJ, McWilliam AS. Th-1/Th-2 switch regulation in immune responses to inhaled antigens. Role of dendritic cells in the aetiology of allergic respiratory disease. Adv Exp Med Biol 1997;417:301-306.
87. 87. Jansen HM. The role of alveolar macrophages and dendritic cells in allergic airway sensitization. Allergy 1996;51:279-292.
88. 88. Thepen T, Kraal G, Holt PG. The role of alveolar macrophages in regulation of lung inflammation. Ann N Y Acad Sci 1994;725:200-206.
89. 89. Thepen T, van Rooijen N, Kraal G. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med 1989;170:499-509.
90. 90. van Haarst JM, Verhoeven GT, de Wit HJ, Hoogsteden HC, Debets R, Drexhage HA. CD1a+ and CD1a-accessory cells from human bronchoalveolar lavage differ in allostimulatory potential and cytokine production. Am J Respir Cell Mol Biol 1996;15:752-759.
91. 91. Thepen T, McMenamin C, Oliver J, Kraal G, Holt PG. Regulation of immune response to inhaled antigen by alveolar macrophages: differential effects of in vivo alveolar macrophage elimination on the induction of tolerance vs. immunity. Eur J Immunol 1991;21:2845-2850.
92. 92. Thepen T, McMenamin C, Girn B, Kraal G, Holt PG. Regulation of IgE production in pre-sensitized animals: in vivo elimination of alveolar macrophages preferentially increases IgE responses to inhaled allergen. Clin Exp Allergy 1992;22:1107-1114.
93. 93. Havenith CE, Breedijk AJ, Betjes MG, Calame W, Beelen RH, Hoefsmit EC. T cell priming in situ by intratracheally instilled antigen-pulsed dendritic cells. Am J Respir Cell Mol Biol 1993;8:319-324.
94. 94. Havenith CE, van Haarst JM, Breedijk AJ, et al. Enrichment and characterization of dendritic cells from human bronchoalveolar lavages. Clin Exp Immunol 1994;96:339-343.
95. 95. Stumbles PA, Thomas JA, Pimm CL, et al. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 1998;188:2019-2031.
96. 96. Rogers PR, Huston G, Swain SL. High antigen density and IL-2 are required for generation of CD4 effectors secreting Th1 rather than Th0 cytokines. J Immunol 1998;161:3844-3852.
97. 97. Schulze-Koops H, Lipsky PE, Davis LS. Human memory T cell differentiation into Th2-like effector cells is dependent on IL-4 and CD28 stimulation and inhibited by TCR ligation. Eur J Immunol 1998;28:2517-2529.
98. 98. Mark DA, Donovan CE, De Sanctis GT, et al. Both CD80 and CD86 co-stimulatory molecules regulate allergic pulmonary inflammation. Int Immunol 1998;10:1647-1655.
99. 99. Larche M, Till SJ, Haselden BM, et al. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J Immunol 1998;161:6375-6382.
100. 100. van den Heuvel MM, Vanhee DD, Postmus PE, Hoefsmit EC, Beelen RH. Functional and phenotypic differences of monocyte-derived dendritic cells from allergic and nonallergic patients. J Allergy Clin Immunol 1998;101(1 Pt 1):90-95.
101. 101. Kapsenberg ML, Hilkens CM, Wierenga EA, Kalinski P. The role of antigen-presenting cells in the regulation of allergen-specific T cell responses. Curr Opin Immunol 1998;10:607-613.
102. 102. Kuper CF, Koomstra PJ, Hameleers DMH, et al. The role of nasopharyngeal lymphoid tissue. Immunol Today 1992;13:219-224.
103. 103. Bellini A, Vittori E, Marini M, Ackerman V, Mattoli S. Intraepithelial dendritic cells and selective activation of Th2-like lymphocytes in patients with atopic asthma [see comments]. Chest 1993;103:997-1005.
104. 104. Fokkens WJ, Vroom T, Rijntjes E, Mulder PGH. Fluctuation of the number of CD1a(T6)-positive dendritic cells, presumably Langerhans cells, in the nasal mucosa of patients with isolated grass-pollen allergy before, during and after the grass-pollen season. J Allergy Clin Immunol 1989;84:39-43.
105. 105. Kraft S, Wessendorf JH, Hanau D, Bieber T. Regulation of the high affinity receptor for IgE on human epidermal Langerhans cells. J Immunol 1998;161:1000-1006.
106. 106. Rajakulasingam K, Durham SR, O'Brien F, et al. Enhanced expression of high-affinity IgE receptor (Fc epsilon RI) alpha chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells. J Allergy Clin Immunol 1997;100:78-86.
107. 107. Haas N, Hamann K, Grabbe J, et al. Demonstration of the high-affinity IgE receptor (Fc epsilon RI) on Langerhans' cells of diseased nasal mucosa. Allergy 1997;52:436-439.
108. 108. KleinJan A, Godthelp T, van Toornenenbergen AW, Fokkens WJ. Allergen binding to specific IgE in the nasal mucosa of allergic patients. J Allergy Clin Immunol 1997;99:515-521.
109. 109. Tunon-De-Lara JM, Redington AE, Bradding P, et al. Dendritic cells in normal and asthmatic airways: expression of the alpha subunit of the high affinity immunoglobulin E receptor (Fc epsilon RI-alpha). Clin Exp Allergy 1996;26:648-655.
110. 110. Maurer D, Ebner C, Reininger B, et al. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol 1995;154:6285-6290.
111. 111. Bieber T, Kraft S, Jurgens M, et al. New insights in the structure and biology of the high affinity receptor for IgE (Fc epsilon RI) on human epidermal Langerhans cells. J Dermatol Sci 1996;13:71-75.
112. 112. Stampfli MR, Rudolf M, Miescher S, Pachlopnik JM, Stadler BM. Antigen-specific inhihition of IgE binding to the high-affinity receptor. J Immunol 1995;155:2948-2954.
113. 113. van der Heijden FL, van Neerven RJ, Kapsenberg ML. Relationship between facilitated allergen presentation and the presence of allergen-specific IgE in serum of atopic patients. Clin Exp Immunol 1995;99:289-293.
114. 114. Fokkens WJ, Holm AF, Rijntjes E, Mulder PGH, Vroom TM. Characterization and quantification of cellular infiltrates in nasal mucosa of patients with grass-pollen allergy, non-allergic patients with nasal polyps and controls. Int Arch Allergy Appl Immunol 1990;93:66-72.
115. 115. Juliusson S, Bachert C, Klementsson H, Karlsson G, Pipkorn U. Macrophages on the nasal mucosal surface in provoked and naturally occurring allergic rhinitis. Acta Otolaryngol (Stockh) 1991;111:946-953.
116. 116. Holt PG, Schon-Hegrad MA, Phillips MJ, McMenamin PG. Ia-positive dendritic cells form a tightly meshed network within the human airway epithelium. Clin Exp Allergy 1989;19:597-601.
117. 117. Schon-Hegrad MA, Oliver J, McMenamin PG, Holt PG. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J Exp Med 1991;173:1345-1356.
118. 118. Holt PG. Regulation of antigen-presenting cell function(s) in lung and airway tissues. Eur Respir J 1993;6:120-129.
119. 119. Holt PG, Oliver J, Bilyk N, et al. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 1993;177:397-407.
120. 120. Thepen T, Hoeben K, Breve J, Kraal G. Alveolar macrophages downregulate local pulmonary immune responses against intratracheally administered T-ecll-dependent, but not T-cell-independent antigens. Immunology 1992;76:60-64.
121. 121. Canque B, Camus S, Yagello M, Gluckman JC. IL-4 and CD4o ligation affect differently the differentiation, maturation, and function of human CD34+ cell-derived CD1a+CD14-and CD1a-CD14+ dendritic cell precursors in vitro. J Leukoc Biol 1998;64:235-244.
122. 122. Ryncarz RE, Anasetti C. Expression of CD86 on human marrow CD34(+) cells identifies immunocompetent committed precursors of macrophages and dendritic cells. Blood 1998;91:3892-3900.
123. 123. Luft T, Pang KC, Thomas E, et al. A serum-free culture model for studying the differentiation of human dendritic cells from adult CD34+ progenitor cells. Exp Hematol 1998;26:489-500.
124. 124. Herbst B, Kohler G, Mackensen A, Veelken H, Lindemann A. GM-CSF promotes differentiation of a precursor cell of monocytes and Langerhans-type dendritic cells from CD34+ haemopoietic progenitor cells. Br J Haematol 1998;101:231-241.
125. 125. Cameron LA, Durham SR, Jacobson MR, et al. Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids J Allergy Clin Immunol 1998;101:330-336.
126. 126. Durham SR, Gould HJ, Thienes CP, et al. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997;27:2899-2906.
127. 127. McWilliam AS, Nelson DJ, Holt PG. The biology of airway dendritic cells. Immunol Cell Biol 1995;73:405-413.
128. 128. Vinke JG, KleinJan A, Severijnen LW, Hoeve LJ, Fokkens WJ. Differences in nasal cellular infiltrates between allergic children and age matched controls. Eur Respir J 1999;13:797-803.
129. 129. Fokkens W. Cellular aspects of nasal immunology. Rhinol Suppl 1992;14:32-36.
130. 130. MacPherson GG, Liu L. Dendritic cells "in vivo": migration and antigen handling. Adv Exp Med Biol 1993;329:327-332.
131. 131. Dandie GW, Watkins FY, Ragg SJ, Holloway PE, Muller HK. The migration of Langerhans' cells into and out of lymph nodes draining normal, carcinogen and antigen-treated sheep skin. Immunol Cell Biol 1994;72:79-86.
132. 132. Winther B, Innes DJ. The human adenoid. A morphologic study [see comments]. Arch Otolaryngol Head Neck Surg 1994;120:144-149.
133. 133. Vinke JG, Fokkens WJ. The role of the adenoid in allergic sensitisation. Int J Pediatr ORL 1999 (in press).
134. 134. Asakura K, Saito H, Hata M, Kataura A. Antigen-specific IgA response of NALT and cervical lymph node cells in antigen-primed rats. Acta Otolaryngol (Stockh) 1998;118:859-863.
135. 135. Yanagita M, Hiroi T, Kitagaki N, et al. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production. J Immunol 1999;162:3559-3565.
136. 136. van Nieuwkerk EB, Kamperdijk EW, Verdaasdonk MA, van der Baan S, Hoefsmit EC. Langerhans cells in the respiratory epithelium of the human adenoid. Eur J Cell Biol 1991;54:182-186.
137. 137. van Nieuwkerk EB, de Wolt CJ, Kamperdijk EW, van der Baan S. Lymphoid and non lymphoid cells in the adenoid of children with otitis media with effusion: a comparative study. Clin Exp Immunol 1990;79:233-239.
138. 138. Forsgren J, Rynnel-Dagoo B, Christensson B. In situ analysis of the immune microenvironment of the adenoid in children with and without secretory otitis media. Ann Otol Rhinol Laryngol 1995;104:189-196.
139. 139. van Nieuwkerk EB, van der Baan S, Hoefsmit EC, Kamperdijk EW. Localization and morphology of antigen-presenting cells in the adenoid of children with otitis media with effusion. Clin Immunol Immunopathol 1995;74:59-69.
140. 140. Hellquist HB, Olsen KE, Irander K, Karlsson E, Odkvist LM. Langerhans cells and subsets of lymphocytes in the nasal mucosa. APMIS 1991;99:449-454.
141. 141. Yoshimi R, Takamura H, Takasaki K, Kumagami H. [Immunohistologic study of the nasal mucosa with reference to Langerhans cells]. Nippon Jibiinkoka Gakkai Kaiho 1993;96:1252-1257.
142. 142. Godthelp T, Holm AF, Blom H, Klein-Jan A, Rijntjes E, Fokkens WJ. The effect of fluticasone propionate aqueous nasal spray on nasal mucosal inflammation in perennial allergic rhinitis. Allergy 1995;50 Suppl 23:21-24.
143. 143. Holm AF, Fokkens WJ, Godthelp T, Mulder PG, Vroom TM, Rijntjes E. Effect of 3 months' nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis. Allergy 1995;50:204-209.
144. 144. Fokkens WJ, Godthelp T, Holm AF, Klein-Jan A. Local corticosteroid treatment: the effect on cells and cytokines in nasal allergic inflammation. Am J Rhinol 1998;12:21-26.
145. 145. Holt PG, Thomas JA. Steroids inhibit uptake and/or processing but not presentation of antigen by airway dendritic cells. Immunology 1997;91:145-150.
146. 146. Bocchino V, Bertorelli G, Zhuo X, et al. Short-term treatment with a low dose of inhaled fluticasone propionate decreases the number of CD1a+ dendritic cells in asthmatic airways. Pulm Pharmacol Ther 1997;10:253-259.
147. 147. van den Heuvel MM, van Beek NM, Broug-Holub E, et al. Glucocorticoids modulate the development of dendritic cells from blood precursors [In Process Citation]. Clin Exp Immunol 1999;115:577-583.
148. 148. Holt PG, Sly PD, Björkstén B. Atopic versus infectious diseases in childhood: a question of balance? Pediatr Allergy Immunol 1997;8:53-58.
149. 149. Ranger AM, Das MP, Kuchroo VK, Glimcher LH. B7-2 (CD86) is essential for the development of IL-4-producing T cells. Int Immunol 1996;8:1549-1560.
150. 150. Greenfield EA, Nguyen KA, Kuchroo VK. CD28/B7 costimulation: a review. Crit Rev Immunol 1998;18:389-418.
151. 151. Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ. Comparative analysis of B7-1 and B7 2 costimulatory ligands: expression and function. J Exp Med 1994;180:631-640.
152. 152. Kuchroo VK, Das MP, Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707-718.
153. 153. Nicholson LB, Kuchroo VK. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol 1996;8:837-842.
154. 154. Mygind N, Dahl R, Nielsen LP. Effect of nasal inflammation and of intranasal anti-inflammatory treatment on bronchial asthma. Respir Med 1998;92:547-549.
155. 155. Frew AJ. Effects of anti-IgE in asthmatic subjects. Thorax 1998:53 Suppl 2:S52-57.
156. 156. Durham SR, Till SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998;102:157-164.
157. 157. Platts-Mills TA, Mueller GA, Wheatley LM. Future directions for allergen immunotherapy. J Allergy Clin Immunol 1998;102:335-343.
158. 158. Heufler C, Koch F, Stanzl U, et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 1996;26:659-668.